Stockscreener 앱 받기
56.76
0.18%
-0.10
시간 외 거래:
56.90
0.14
+0.25%
Crispr Therapeutics Ag 주식(CRSP)의 최신 뉴스
Sumitomo Mitsui Trust Group Inc. Sells 205,564 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics Touts “Second Phase” After Casgevy, Eyes 6 Data Readouts in 6–12 Months - MarketBeat
CRISPR Therapeutics Improves Cash Position Amid Pipeline Expansion - Intellectia AI
2 Billion Reasons to Love CRISPR Therapeutics Right Now - The Motley Fool
Momentum Shift: Is CRISPR Therapeutics AG a strong growth stock2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
Published on: 2026-04-13 17:48:33 - baoquankhu1.vn
Aug Highlights: What is the long term forecast for CRISPR Therapeutics AG stockMarket Sentiment Review & Entry Point Strategy Guides - baoquankhu1.vn
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know - MSN
Is CRISPR Therapeutics (CRSP) Pricing In Too Much Hope After Recent Share Price Recovery - Yahoo Finance
CRISPR’s One-Time ANGPTL3 Edit for Lipids Might Change The Case For Investing In CRISPR Therapeutics (CRSP) - Sahm
Bank Watch: What is the long term forecast for CRISPR Therapeutics AG stockWeekly Stock Report & Daily Market Momentum Tracking - baoquankhu1.vn
Is CRISPR Therapeutics AG a strong growth stock2026 Technical Patterns & Expert Approved Trade Ideas - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
CRSP Stock Price, Quote & Chart | CRISPR THERAPEUTICS AG (NASDAQ:CRSP) - ChartMill
Why is CRISPR Therapeutics AG stock going down2026 Technical Patterns & Daily Growth Stock Investment Tips - baoquankhu1.vn
Is CRISPR Therapeutics (CRSP) Pricing Reflect Its Sharp Five‑Year Share Price Pullback - simplywall.st
Bank of America Securities Remains a Buy on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Price-Driven Insight from (CRSP) for Rule-Based Strategy - Stock Traders Daily
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo! Finance Canada
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Sell Signal: Should I set a stop loss on CRISPR Therapeutics AG2026 Volume Leaders & Proven Capital Preservation Methods - baoquankhu1.vn
CRISPR Therapeutics: Potential Breakthroughs in Gene Editing - Intellectia AI
Can CRISPR Therapeutics AG stock outperform in a bear marketStock Surge & Long-Term Capital Growth Ideas - baoquankhu1.vn
Del-Sette Capital Management, LLC's CRISPR Therapeutics AG(CRSP) Holding History - GuruFocus
CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - sg.finance.yahoo.com
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Genome Editing Market Is Going to Boom |• CRISPR Therapeutics • Editas Medicine - openPR.com
CRISPR Therapeutics AG (CRSP) latest stock news and headlines - Yahoo Finance Australia
Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Revenue And Cash Position Support Its Growth Transition - Sahm
LTS:0VRQ PB Ratio: 2.47 — 22% Below Median - GuruFocus
CRISPR Therapeutics Hits Day Low of $50.66 Amid Price Pressure - Markets Mojo
Did CRISPR’s Cash Raise, Casgevy Launch and Insider Buying Just Shift CRISPR Therapeutics' (CRSP) Investment Narrative? - Sahm
CRISPR Therapeutics AG (CRSP) rises higher than market: Key facts - MSN
2.69%
0.25%
자본화:
|
볼륨(24시간):